LUCD · Lucid Diagnostics Inc. · Webcasts, Transcripts & Audio
$0.43
-0.02 (-4.83%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Nov 12, 2026
Market Cap
$92.95M
Shares
206.98M
Volume · Nov 16
1.14M
Avg daily vol (3M)
4.99M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Lucid Diagnostics Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Lucid Diagnostics Inc. (LUCD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-12
Lucid Diagnostics Inc. (LUCD) Q3 2026 Earnings Call Transcript
Confident tone
Medicare reimbursement and commercial acceleration
CMS LCD process and administrative backlog
Commercial payer coverage
Revenue
$1.20M
▼ 0.7% YoY Gross margin
-16.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-13
Lucid Diagnostics Inc. (LUCD) Q2 2026 Earnings Call Transcript
Positive tone
Test volume and revenue
CONCERT LBM coverage
Medicare LCD
Revenue
$1.47M
▲ 26.7% YoY Gross margin
2.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-08-11
Lucid Diagnostics Inc. (LUCD) August 11, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-14
Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call Transcript
Positive tone
Test volume and sales productivity
Operating expenses and cash burn
Balance sheet and financing
Revenue
$1.26M
▲ 51.7% YoY Gross margin
-29.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-04-16
Lucid Diagnostics Inc. (LUCD) April 16, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-03-26
Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call Transcript
Positive tone
Medicare reimbursement and MolDx LCD
EsoGuard test volume and revenue
Real-world EsoGuard/EsoCheck study
Revenue
$1.50M*
▲ 25.6% YoY Gross margin
-23.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript
Confident tone
Medicare / MolDx CAC Meeting
EsoGuard Commercial Volume and Revenue
Market Access and Commercial Payer Coverage
Revenue
$1.21M
▲ 3.3% YoY Diluted EPS
$-0.10
Gross margin
-40.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript
Positive tone
Medicare LCD / CAC meeting
EsoGuard test volume and revenue
Hoag health system partnership
Revenue
$1.16M
▲ 19.2% YoY Diluted EPS
$-0.08
Gross margin
-34.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Lucid Diagnostics Inc. (LUCD) Q1 2025 Earnings Call Transcript
Confident tone
Cash-pay concierge medicine channel
Medicare/MolDX reimbursement
Employer and fire department testing
Revenue
$828,000
▼ 17.3% YoY Diluted EPS
$-0.52
Gross margin
-87.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-25
Lucid Diagnostics Inc. (LUCD) Q4 2024 Earnings Call
Revenue
$1.20M*
▲ 15.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Lucid Diagnostics Inc. (LUCD) Q3 2024 Earnings Call Transcript
Confident tone
Commercial volume and revenue
Medicare/CMS coverage submission
Clinical evidence and validation
Revenue
$1.17M
▲ 49.7% YoY Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Lucid Diagnostics Inc. (LUCD) Q2 2024 Earnings Call Transcript
Positive tone
Clinical data and validation studies
Direct contracting and guaranteed revenue
Check Your Food Tube (CYFT) health fair events
Revenue
$976,000
▲ 513.8% YoY Diluted EPS
$-0.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Lucid Diagnostics Inc. (LUCD) Q1 2024 Earnings Call Transcript
Confident tone
EsoGuard Clinical Performance
Revenue and Test Volume
MolDX Medicare Coverage
Revenue
$1.00M
▲ 124.4% YoY Diluted EPS
$-0.40
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2023-11-14
Lucid Diagnostics Inc. (LUCD) Q3 2023 Earnings Call Transcript
Revenue
$783,000
▲ 930.3% YoY Diluted EPS
$-0.34
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Lucid Diagnostics Inc. (LUCD) Q2 2023 Earnings Call Transcript
Revenue
$159,000
Diluted EPS
$-0.27
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
Lucid Diagnostics Inc. (LUCD) Q1 2023 Earnings Call Transcript
Revenue
$446,000
▲ 136% YoY Diluted EPS
$-0.40
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-14
Lucid Diagnostics Inc. (LUCD) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Lucid Diagnostics Inc. (LUCD) Q3 2022 Earnings Call Transcript
Revenue
$76,000
▼ 62% YoY Diluted EPS
$-0.39
Gross margin
100.0%
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
Lucid Diagnostics Inc. (LUCD) Q2 2022 Earnings Call Transcript
Diluted EPS
$-0.41
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Lucid Diagnostics Inc. (LUCD) Q1 2022 Earnings Call Transcript
Revenue
$189,000
Gross margin
-95.2%
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-28
Lucid Diagnostics Inc. (LUCD) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–21 of 21 webcasts
Key facts
CIK
1799011
CUSIP
54948X109
13F (30d)
77 filings
73 filers
Visit website
Investor relations